"Estrogen Carcinogenicity." . . "Catechol estrogens Side effects." . . "Cancer." . . "Tumeurs induit chimiquement." . . "Estrogens adverse effects." . . "Estrogens adverse effects" . "Contraception Complications et séquelles." . . "Electronic books." . . "Electronic books" . "Hormontherapie Menopause Carcinogenität." . . "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans" . . "Oestrogènes usage thérapeutique." . . "Cancer Risk factors." . . "Catechol estrogens Carcinogenicity." . . "Estrogens therapeutic use." . . "Estrogens therapeutic use" . "Estrogen Side effects." . . "Oral contraceptives Carcinogenicity." . . "Progestins adverse effects." . . "Progestins adverse effects" . "Neoplasms prevention & control." . . "Neoplasms prevention & control" . "International Agency for Research on Cancer (Lyon). Working Group on the Evaluation of Carcinogenic Risks to Humans." . . "Progestins therapeutic use." . . "Progestins therapeutic use" . "Menopause Hormontherapie Carcinogenität." . . "Chemical carcinogenesis." . . "Contraceptifs oraux combinés effets indésirables." . . "Contraceptives, Oral, Combined adverse effects." . . "Contraceptives, Oral, Combined adverse effects" . "Femmes Maladies." . . "World Health Organization" . . . . . . . . . "Combined Estrogen-Progestogen contraceptives and combined Estrogen-Progestogen menopausal therapy" . . . . . . "Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy"@en . . "Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy" . . "Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monograp." . "Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monograp."@en . "Livres électroniques" . . . "Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy" . . . . . . "This ninety-first volume of IARC Monographs contains evaluations of the carcinogenic hazard to humans of combined estrogen-progestogen contraceptives and combined estrogen-protestogen menopausal therapy. The hormonal drugs reviewed in this volume involve co-administration of an estrogen and a progestogen. Studies that did not provide information on the use of combined estrogen-progestogen agents are not reviewed. It should also be noted that this volume reviews only studies that are publicly available and therefore does not include pharmaceutical test results that are not in the public domain." . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy : this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7 - 14 June 2005" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Electronic books"@en . "Electronic books" . . . . . . . . . "IARC monographs on the evaluation of carcinogenic risks to humans, volume 91, Combined Estrogen-Progestogen contraceptives and combined Estrogen-Progestogen menopausal therapy : this publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7 - 14 June 2005" . . . . "Hormonothérapie substitutive effets indésirables." . . "Meeting. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2005.06.07-14 Lyon)" . . . "Progestines therapeutic use." . . "International Agency for Research on Cancer" . . . "Catécholœstrogènes Cancérogénicité." . . "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2005 : Lyon, France)" . . . "Hormone Replacement Therapy adverse effects." . . "Hormone Replacement Therapy adverse effects" . "Oestrogènes effets indésirables." . . "Progestatifs Cancérogénicité." . . "Catécholœstrogènes Effets secondaires." . . "Carcinogens Congresses." . . "Cancérogenèse chimique." . . "IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (Lyon,France)." . . "Menopause." . . "Risk Assessment Congresses." . . "Contraception Estrogens Adverse effects." . . . . "Hormonale Empfängnisverhütung Carcinogenität." . . "Women." . . "Contraceptives, Oral, Hormonal adverse effects." . . "Contraceptives, Oral, Hormonal adverse effects" . "Kongress (2005 : Lyon, France)" . . . "IARC working group on the evaluation of carcinogenic risks to humans (2005 ; Lyon)." . . . "Progestines effets indésirables." . . "IARC working group on the evaluation of carcinogenic risks to humans (07-06-2005 - 14-06-2005 : Lyon)" . . . "Cancer Facteurs de risque." . . "Progestational hormones Side effects." . . "Tumeurs prévention et contrôle." . . "Contraception Complications." . . "HEALTH & FITNESS Diseases Cancer." . . "MEDICAL Oncology." . . "Progestatifs Effets secondaires." . . "Hormone Replacement Therapy adverse effects Congresses." . . "Women Diseases Risk factors." . . "International Agency for Research on Cancer. Working Group on the Evaluation of Carcinogenic Risks to Humans." . . "Neoplasms chemically induced." . . "Neoplasms chemically induced" . "Menopause Hormone therapy Complications." . . "Catechol estrogens." . . "Ménopause Hormonothérapie Complications et séquelles." . . "Progestins adverse effects Congresses." . . "Progestational hormones Carcinogenicity." . . "Estrogens adverse effects Congresses." . . "Carcinogenität Hormonale Empfängnisverhütung." . . "Contraception." . . "Contraceptives, Oral, Hormonal adverse effects Congresses." . . "Progestational hormones." . . "Contraceptifs oraux hormonaux effets indésirables." . . "Carcinogenität Menopause Hormontherapie." . .